Open Access. Powered by Scholars. Published by Universities.®
Articles 31 - 60 of 106
Full-Text Articles in Medicine and Health Sciences
Impact Of Covid-19 On Serum Melatonin Levels And Sleep Parameters In Children, Özlem Yayici Köken, Pembe Gültutan, Merve Si̇bel Güngören, Gülsüm İclal Bayhan, Deni̇z Yilmaz, Esra Gürkaş, Hami̇t Özyürek, Ayşegül Neşe Çitak Kurt
Impact Of Covid-19 On Serum Melatonin Levels And Sleep Parameters In Children, Özlem Yayici Köken, Pembe Gültutan, Merve Si̇bel Güngören, Gülsüm İclal Bayhan, Deni̇z Yilmaz, Esra Gürkaş, Hami̇t Özyürek, Ayşegül Neşe Çitak Kurt
Turkish Journal of Medical Sciences
Background/aim: This study aimed to analyze the serum melatonin levels and changes in sleep patterns in pediatric patients with coronavirus disease 2019 (COVID-19). Materials and methods: This study was designed as a descriptive, cross-sectional study. Serum melatonin levels and sleep parameters of children with the diagnosis of COVID-19 who had mild and moderate disease (i.e., COVID-19 group) were compared with those of children admitted with non-COVID-19 nonspecific upper respiratory tract infection (i.e., control group). The sleep disturbance scale for children (SDSC) questionnaire was applied to the participants' primary caregivers to analyze their sleep patterns at present and six months before …
Hydroxychloroquine Plus Azithromycin And Early Hospital Admission Are Beneficial Incovid-19 Patients: Turkish Experience With Real-Life Data, Eli̇f Tanriverdi̇, Mustafa Çörtük, Bi̇nnaz Zeynep Yildirim, Efsun Gonca Uğur Chousein, Demet Turan, Hali̇t Çinarka, Mehmet Aki̇f Özgül, Erdoğan Çeti̇nkaya
Hydroxychloroquine Plus Azithromycin And Early Hospital Admission Are Beneficial Incovid-19 Patients: Turkish Experience With Real-Life Data, Eli̇f Tanriverdi̇, Mustafa Çörtük, Bi̇nnaz Zeynep Yildirim, Efsun Gonca Uğur Chousein, Demet Turan, Hali̇t Çinarka, Mehmet Aki̇f Özgül, Erdoğan Çeti̇nkaya
Turkish Journal of Medical Sciences
Background/aim: New treatment regimens for COVID-19, which has threatened the world recently, continue to be investigated. Although some of the treatments are promising, it is thought to be early to state that there is definitive treatment. Experiences and treatment protocol studies from treatment centers are still important. The aim of this study is to evaluate factors affecting the treatment process of the first cases followed in our clinic. Materials and methods: The consecutive hospitalized patients with COVID-19 pneumonia were analyzed in this retrospective and cross-sectional study. Data were recorded from the electronic and written files of patients. Results: Eighty-three patients …
Hepatitis A Susceptibility Parallels High Covid-19 Mortality, Fai̇k Sariali̇oğlu, Fatma Burcu Belen, Kadi̇r Mutlu Hayran
Hepatitis A Susceptibility Parallels High Covid-19 Mortality, Fai̇k Sariali̇oğlu, Fatma Burcu Belen, Kadi̇r Mutlu Hayran
Turkish Journal of Medical Sciences
Background/aim:COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. Materials and methods: As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people infected and 413,733 dead. This data was combined with the World Health Organization susceptibility classification on the worldwide prevalence of HAV, and the relationship between HAV susceptibility and COVID-19 mortality were analyzed. Results: When the data from 213 countries were analyzed, it was found that there was a significant increasing trend in COVID-19 mortality rates …
Interleukin-21: A Potential Biomarker For Diagnosis And Predicting Prognosis In Covid-19 Patients, Ni̇lüfer Ayli̇n Acet Öztürk, Ahmet Ursavaş, Asli Görek Di̇lektaşli, Ezgi̇ Demi̇rdöğen, Necmi̇ye Funda Coşkun, Dane Edi̇ger, Ayşe Esra Uzaslan, Di̇ğdem Yöyen Ermi̇ş, Mert Karaca, Orkun Eray Terzi̇, Merve Bayram, Di̇lara Ömer Topçu, Büşra Yi̇ği̇tli̇ler, Ahmet Yurttaş, Shahri̇yar Maharramov
Interleukin-21: A Potential Biomarker For Diagnosis And Predicting Prognosis In Covid-19 Patients, Ni̇lüfer Ayli̇n Acet Öztürk, Ahmet Ursavaş, Asli Görek Di̇lektaşli, Ezgi̇ Demi̇rdöğen, Necmi̇ye Funda Coşkun, Dane Edi̇ger, Ayşe Esra Uzaslan, Di̇ğdem Yöyen Ermi̇ş, Mert Karaca, Orkun Eray Terzi̇, Merve Bayram, Di̇lara Ömer Topçu, Büşra Yi̇ği̇tli̇ler, Ahmet Yurttaş, Shahri̇yar Maharramov
Turkish Journal of Medical Sciences
Background/aim: COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common γ-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients hospitalized with COVID-19. Materials and methods: Patients with a preliminary diagnosis of COVID-19 and pneumonia other than COVID-19 admitted to a tertiary care hospital were included consecutively in this comparative study. Results: The study population consisted of 51 patients with COVID-19 and 11 …
Decrease Of Left Ventricular Ejection Fraction In Severe Illness Patients Due To Covid-19may Improve As The Disease Resolves, Aykut Demi̇rkiran, Lütfi̇ Çağatay Onar, Mustafa Doğan
Decrease Of Left Ventricular Ejection Fraction In Severe Illness Patients Due To Covid-19may Improve As The Disease Resolves, Aykut Demi̇rkiran, Lütfi̇ Çağatay Onar, Mustafa Doğan
Turkish Journal of Medical Sciences
Background/aim: Increase in publications supporting myocardial involvement in the COVID-19 disease has led to need to gain insight into the the global burden of heart failure after pandemic. We examined the course of myocardial systolic function in patients without elevated troponin levels. Materials and methods: We performed a prospective study. Patients with high troponin levels were excluded from the study in order to definitively exclude complications known to cause permanent left ventricular systolic dysfunction, such as acute coronary syndromes. Two echocardiographic examinations were performed. The first evaluation was performed within the days of hospitalization, if possible, on the day when …
Do Initial Hematologic Indices Predict The Severity Of Covid-19 Patients?, Ali̇ Asan, Yasemi̇n Üstündağ, Ni̇zameddi̇n Koca, Abdullah Şi̇mşek, Hali̇l Erkan Sayan, Hülya Parildar, Burcu Dalyan Ci̇lo, Kağan Huysal
Do Initial Hematologic Indices Predict The Severity Of Covid-19 Patients?, Ali̇ Asan, Yasemi̇n Üstündağ, Ni̇zameddi̇n Koca, Abdullah Şi̇mşek, Hali̇l Erkan Sayan, Hülya Parildar, Burcu Dalyan Ci̇lo, Kağan Huysal
Turkish Journal of Medical Sciences
Background/aim: In this study, we aimed to evaluate the initial hematological findings analyzed on admission in confirmed COVID-19 patients who were transferred to the intensive care unit (ICU), to predict possible hematological indices. Materials and methods: Initial neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), monocyte to lymphocyte ratio (MLR), red cell distribution width to platelet ratio (RPR), mean platelet volume to platelet ratio, and lymphocyte multiplied by platelet count (LYM × PLT), of 695 patients with laboratory-confirmed COVID-19 were investigated and comparisons were made between the mild/moderate and severe groups. Results: The proportion of COVID-19 cases admitted …
Tocilizumab And Covid-19: A Meta-Analysis Of 2120 Patients With Severe Disease Andimplications For Clinical Trial Methodologies, Azza Sarfraz, Zouina Sarfraz, Muzna Sarfraz, Hinna Aftab, Zainab Pervaiz
Tocilizumab And Covid-19: A Meta-Analysis Of 2120 Patients With Severe Disease Andimplications For Clinical Trial Methodologies, Azza Sarfraz, Zouina Sarfraz, Muzna Sarfraz, Hinna Aftab, Zainab Pervaiz
Turkish Journal of Medical Sciences
Background/aim: Since the outbreak of the COVID-19, numerous therapies to counteract this severe disease have emerged. The benefits of Tocilizumab for severely infected COVID-19 patients and the methodologies of ongoing clinical trials are explored. Materials and methods: A systematic search adhering to PRISMA guidelines was conducted in PubMed, Cochrane Central, medRxiv, and bioRxiv using the following keywords: "Tocilizumab," "Actemra," "COVID-19." An additional subsearch was conducted on Clinicaltrials.gov to locate ongoing tocilizumab trials. Results: A total of 13 studies were included in the meta-analysis comprising 2120 patients. The treatment group had lower mortality compared to the control group (OR = 0.42, …
Evaluation Of Systemic Involvement Of Coronavirus Disease 2019 Through Spleen; Size Andtexture Analysis, Abdussamet Batur, Abi̇di̇n Kilinçer, Fati̇h Ateş, Nazlim Aktuğ Demi̇r, Recai̇ Ergün
Evaluation Of Systemic Involvement Of Coronavirus Disease 2019 Through Spleen; Size Andtexture Analysis, Abdussamet Batur, Abi̇di̇n Kilinçer, Fati̇h Ateş, Nazlim Aktuğ Demi̇r, Recai̇ Ergün
Turkish Journal of Medical Sciences
Background/aim: To investigate the changes in the spleen size, parenchymal heterogeneity, and computed tomography (CT) texture analysis features of patients diagnosed with Coronavirus disease 2019 (COVID-19) Materials and methods: The size and parenchymal structure of the spleen in 91 patients who underwent thoracic CT examination due to COVID-19 were evaluated. For the evaluation of parenchymal heterogeneity, CT texture analysis was performed using dedicated software (Olea Medical, France). The texture analysis of each case consisted of 15 first-order intensity-based features, 17 gray level cooccurrence matrix-based features, and 9 gray level run length matrix-based features. Results: A total of 91 patients (45 …
Clinical Characteristics And Risk Factors For 28-Day Mortality In Critically Ill Patients With Covid-19: A Retrospective Cohort Study, Mehmet Nuri̇ Yakar, Begüm Ergan, Bi̇şar Ergün, Murat Küçük, Ali̇ Cantürk, Mahmut Cem Ergon, Naci̇ye Si̇nem Gezer, Erdem Yaka, Bi̇lgi̇n Cömert, Ali̇ Necati̇ Gökmen
Clinical Characteristics And Risk Factors For 28-Day Mortality In Critically Ill Patients With Covid-19: A Retrospective Cohort Study, Mehmet Nuri̇ Yakar, Begüm Ergan, Bi̇şar Ergün, Murat Küçük, Ali̇ Cantürk, Mahmut Cem Ergon, Naci̇ye Si̇nem Gezer, Erdem Yaka, Bi̇lgi̇n Cömert, Ali̇ Necati̇ Gökmen
Turkish Journal of Medical Sciences
Background: To date, the coronavirus disease 2019 (COVID-19) caused more than 2.6 million deaths all around the world. Risk factors for mortality remain unclear. The primary aim was to determine the independent risk factors for 28-day mortality. Materials and Methods: In this retrospective cohort study, critically ill patients (≥ 18 years) who were admitted to the intensive care unit due to COVID-19 were included. Patient characteristics, laboratory data, radiologic findings, treatments, and complications were analyzed in the study. Results: A total of 249 patients (median age 71, 69.1% male) were included in the study. 28-day mortality was 67.9% (n = …
Effects Of Hydroxychloroquine And Favipiravir On Clinical Course In Outpatients Withcovid-19, Seyda Kayhan Ömeroğlu, Fehmi̇naz Temel, Di̇lek Altun, Mehmet Burak Öztop
Effects Of Hydroxychloroquine And Favipiravir On Clinical Course In Outpatients Withcovid-19, Seyda Kayhan Ömeroğlu, Fehmi̇naz Temel, Di̇lek Altun, Mehmet Burak Öztop
Turkish Journal of Medical Sciences
Background/aim: Due to the importance of early outpatient treatment to prevent hospitalization and disease progression, we examined the effects of hydroxychloroquine and favipiravir, which were initiated in early period, on the clinical course of COVID-19 outpatients. Materials and methods: Data of confirmed COVID-19 outpatients over a 4-month period were analyzed retrospectively. Public Health Management System (HSYS) was used for the case-based follow-up. Patients on antiviral therapy for at least five days, including hydroxychloroquine and / or favipiravir and patients who were followed-up for 30 days were included in this analysis. Results: We enrolled 1489 patients in this study. Overall, 775 …
Achievements Of The Covid-19 Turkey Platform In Vaccine And Drug Development Withan Approach Of "Co-Creation And Succeeding Together", Hasan Mandal
Turkish Journal of Medical Sciences
Mobilizing the research ecosystem for accelerating vaccine and drug development has been an important reality of the pandemic. This article reviews the scientific advances that are attained by the COVID-19 Turkey Platform for vaccine and drug development against the SARS-CoV-2 virus. The platform that is coordinated by the Scientific and Technological Research Council of Turkey is established with a "co-creation and succeeding together" approach, which involves 436 researchers across 49 different institutions working on 17 vaccine and drug development projects in total. Recent advances of the COVID-19 Turkey Platform include the fourth virus-like particle-based vaccine candidate in the world to …
Turkey's Response To Covid-19 Pandemic: Strategy And Key Actions, Gülşen Barlas, Harun Öztürk, Gülen Pehli̇vantürk, Sabahatti̇n Aydin
Turkey's Response To Covid-19 Pandemic: Strategy And Key Actions, Gülşen Barlas, Harun Öztürk, Gülen Pehli̇vantürk, Sabahatti̇n Aydin
Turkish Journal of Medical Sciences
COVID-19 emerged at the end of 2019 in Wuhan, China, and spread rapidly around the world causing many deaths. Due to the intercontinental escalation in the epidemic, while WHO declared a pandemic on March 11, 2020, our country's first case was diagnosed. Before this, the MoH established the Operations Center against possible risks regarding the Pandemic Influenza Preparedness Plan on January 10, 2020 and formed the Scientific Committee, which has a critical importance in epidemic management. National and Provincial Pandemic Coordination Boards were established within the scope of this plan. Fast, effective and frequently updated decisions were implemented. The epidemic …
One And A Half Years Into The Covid-19 Pandemic - Exit Strategies And Efficacy Of Sarscov-2 Vaccines For Holistic Management And Achieving Global Control, Eskild Petersen, Ayşe Deni̇z Gökengi̇n, Asma Al Balushi, Alimuddin Zumla
One And A Half Years Into The Covid-19 Pandemic - Exit Strategies And Efficacy Of Sarscov-2 Vaccines For Holistic Management And Achieving Global Control, Eskild Petersen, Ayşe Deni̇z Gökengi̇n, Asma Al Balushi, Alimuddin Zumla
Turkish Journal of Medical Sciences
One and a half years into the pandemic, SARS-CoV-2 is still here to stay. Whilst rapid several effective COVID-19 vaccines have been developed and are being rolled out, the critical questions remain whether vaccines provide widespread protection against infection and reinfection, and what the duration of protection is. Community wide control cannot be obtained until almost everyone is immune. Vaccine production must be ramped up to cover the world population. The price of herd immunity through natural infection is high mortality in the elderly and morbidity in other age groups including children and Long-COVID. We must expect a new wave …
Going Back To Normal, But How? Re-Opening Policies And The Standards For A New Normal, Levent Akin
Going Back To Normal, But How? Re-Opening Policies And The Standards For A New Normal, Levent Akin
Turkish Journal of Medical Sciences
Governments implemented to nonpharmacological methods and various limitation policies such as closing nonessential businesses, schools and limiting group gatherings, promoting social distancing, use of personal protective equipment, advising staying at home. These policies have caused various problems in social and economic life and gradual increase in psychosocial well-being problems. All societies yearningly are waiting for the COVID-19 pandemic to be brought under control and the measures to be lifted in order to return to their previous lives. Indicators are needed to assess the burden of disease in the country while lifting measures to control the COVID-19 pandemic. When using these …
Epidemiology Of Covid-19: What Changed In One Year?, Cemal Bulut, Yasuyuki̇ Kato
Epidemiology Of Covid-19: What Changed In One Year?, Cemal Bulut, Yasuyuki̇ Kato
Turkish Journal of Medical Sciences
A coronavirus brought the first pandemic attack of this century as a flu virus did a hundred years ago. This greatest pandemic of the century brings us new opportunities to understand and explore the dynamics of a contagious disease. Nearly two years later, we are still collecting the evidence to understand the disease. Some basic epidemiological properties are still urgently needed. Not only the origin of the virus but also Ro value, possible transmission routes, epidemiologic curves, case fatality rates, seasonality, severity and mortality risk factor, effects on the risk groups, differences between countries and so on still require strong …
From Asymptomatic To Critical Illness - Different Clinical Manifestations Of Covid-19 Inchildren, Hasan Tezer, Meli̇s Deni̇z
From Asymptomatic To Critical Illness - Different Clinical Manifestations Of Covid-19 Inchildren, Hasan Tezer, Meli̇s Deni̇z
Turkish Journal of Medical Sciences
The global pandemic infectious disease that was named the new coronavirus disease (COVID 19), spread throughout the world, causing a major public health emergency. The causative virus of COVID-19, called SARS CoV-2, can infect all age groups. Various clinical signs and symptoms have been observed in neonates, children, and adolescents during the COVID-19 outbreak. The clinical manifestations of COVID-19 might be different due to the medical conditions and comorbid status in elderly and pediatric patients. The rise in cases among children has been reported during the COVID-19 pandemic. Although infected children generally appear to be asymptomatic or have only mild …
Multisystem Inflammatory Syndrome In Children, Selda Hançerli̇ Törün, Di̇lek Yilmaz Çi̇ftdoğan, Ateş Kara
Multisystem Inflammatory Syndrome In Children, Selda Hançerli̇ Törün, Di̇lek Yilmaz Çi̇ftdoğan, Ateş Kara
Turkish Journal of Medical Sciences
As the COVID-19 pandemic continues, children can be infected with the virus that causes COVID-19. Clinical symptoms of children with COVID from China, where the disease was first reported, generally were less severe than adults. However, at the end of April 2020 in Europe, it was observed that some children with SARS-CoV-2 infection developed fever, abdominal pain, shock, myocardial insufficiency and they needed to be taken care of in intensive care unit. This new disease has been called multisystem inflammatory syndrome in children (MIS-C). Although the pathogenesis of MIS-C is unclear, it progresses with signs of multiorgan involvement as a …
From Asymptomatic To Critical Illness: Decoding Various Clinical Stages Of Covid-19, İlhami̇ Çeli̇k, Recep Öztürk
From Asymptomatic To Critical Illness: Decoding Various Clinical Stages Of Covid-19, İlhami̇ Çeli̇k, Recep Öztürk
Turkish Journal of Medical Sciences
The clinical course of COVID-19 is variable, with clinical manifestation ranging from 81% mild course to 14% severe course along with 5% critical course in patients. The asymptomatic course is reported to potentially range between 20% and 70% (avg. 33%). A more severe course is seen in the elderly, those with various chronic diseases, and the immunosuppressed, where the case fatality rate is higher in these risk groups. The disease progresses with various symptoms, such as fever, cough, shortness of breath, malaise, myalgia, taste and smell disorders, diarrhea, sore throat, headache, and conjunctivitis. The disease begins with shortness of breath, …
Covid-19 And Sepsis, Zeli̇ha Koçak Tufan, Bi̇rcan Kayaaslan, Mervyn Mer
Covid-19 And Sepsis, Zeli̇ha Koçak Tufan, Bi̇rcan Kayaaslan, Mervyn Mer
Turkish Journal of Medical Sciences
The COVID-19 pandemic has created a major alteration in the medical literature including the sepsis discussion. From the outset of the pandemic, various reports have indicated that although there are some unique features pertinent to COVID-19, many of its acute manifestations are similar to sepsis caused by other pathogens. As a consequence, the old definitions now require consideration of this new etiologic agent, namely SARS-CoV-2. Although the pathogenesis of COVID-19 has not been fully explained, the data obtained so far in hospitalized patients has revealed that serum cytokine and chemokine levels are high in severe COVID-19 patients, similar to those …
Pregnancy And Covid-19: Prevention, Vaccination, Therapy, And Beyond, Di̇lek Şahi̇n, Atakan Tanaçan, Sophia Ne Webster, Özlem Moraloğlu Teki̇n
Pregnancy And Covid-19: Prevention, Vaccination, Therapy, And Beyond, Di̇lek Şahi̇n, Atakan Tanaçan, Sophia Ne Webster, Özlem Moraloğlu Teki̇n
Turkish Journal of Medical Sciences
: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has alarmed the world since its first emergence. As pregnancy is characterized by significant changes in cardiovascular, respiratory, endocrine, and immunological systems, there are concerns on issues like the course of disease in pregnant women, safety of medications, route of delivery and risk of obstetric complications. The aim of this review is to summarize the current literature in the management of pregnant women during the COVID-19 pandemic. Although more than 90% of pregnant women with COVID-19 recover without serious morbidity, rapid deterioration of disease and higher …
The Radiological Findings Of Covid-19, Alper Karacan, Yakup Ersel Aksoy, Mehmet Hali̇l Öztürk
The Radiological Findings Of Covid-19, Alper Karacan, Yakup Ersel Aksoy, Mehmet Hali̇l Öztürk
Turkish Journal of Medical Sciences
Background/aim: Available information on the radiological findings of the 2019 novel coronavirus disease (COVID-19) is constantly updated. Ground glass opacities (GGOs) and consolidation with bilateral and peripheral distribution have been reported as the most common CT findings, but less typical features can also be identified. According to the reported studies, SARS-CoV-2 infection is not limited to the respiratory system, and it can also affect other organs. Renal dysfunction, gastrointestinal complications, liver dysfunction, cardiac manifestations, and neurological abnormalities are among the reported extrapulmonary features. This review aims to provide updated information for radiologists and all clinicians to better understand the radiological …
Immune Dysfunction In Covid-19 And Judicious Use Of Antirheumatic Drugs For Thetreatment Of Hyperinflammation, Abdurrahman Tufan, Marco Matucci-Cerinic
Immune Dysfunction In Covid-19 And Judicious Use Of Antirheumatic Drugs For Thetreatment Of Hyperinflammation, Abdurrahman Tufan, Marco Matucci-Cerinic
Turkish Journal of Medical Sciences
: In the Wuhan province of China, almost two years ago, in December 2019, the novel Coronavirus 2019 has caused a severe involvement of the lower respiratory tract leading to an acute life-threatening respiratory syndrome, coronavirus disease-19 (COVID-19). Subsequently, coronavirus 2 (SARS-CoV-2) rapidly spread to the entire world causing a pandemic and affected every single person on earth either directly or indirectly with destroying all facets of social life and economy. Since the announcement of COVID-19 as a global pandemic, we have witnessed tremendous scientific work on all aspects of COVID-19 across the globe, which has never been witnessed before. …
An Update Of Anti-Viral Treatment Of Covid-19, Serap Yavuz, Feri̇de İpek Komsuoğlu Çeli̇kyurt
An Update Of Anti-Viral Treatment Of Covid-19, Serap Yavuz, Feri̇de İpek Komsuoğlu Çeli̇kyurt
Turkish Journal of Medical Sciences
Background/aim: Currently there is not an effective antiviral treatment for COVID-19, but a large number of drugs have been evaluated since the beginning of the pandemic, and many of them have been used for the treatment of COVID-19 despite the preliminary or conflicting results of the clinical trials. We aimed to review and summarize all of the current knowledge on the antivirals for COVID-19. Results: There are 2 main drug groups for SARS-CoV-2: agents that target proteins or RNA of the virus or interfere with proteins or biological processes in the host that support the virus. The main drug groups …
Consensus Recommendations For Botulinum Toxin Injections In The Spasticitymanagement Of Children With Cerebral Palsy During Covid-19 Outbreak, Ebru Yilmaz Yalçinkaya, Nai̇me Evri̇m Karadağ Saygi, Özden Özyemi̇şci̇ Taşkiran, Nalan Çapan, Şehi̇m Kutlay, Bi̇rkan Sonel Tur, Özlem El, Ece Ünlü Akyüz, Süda Teki̇n, Demet Ofluoğlu, Murat Zi̇nnuroğlu, Pinar Akpinar, Tuğçe Özekli̇ Misirlioğlu, Berri̇n Hüner, Ahmet Hakan Nur
Consensus Recommendations For Botulinum Toxin Injections In The Spasticitymanagement Of Children With Cerebral Palsy During Covid-19 Outbreak, Ebru Yilmaz Yalçinkaya, Nai̇me Evri̇m Karadağ Saygi, Özden Özyemi̇şci̇ Taşkiran, Nalan Çapan, Şehi̇m Kutlay, Bi̇rkan Sonel Tur, Özlem El, Ece Ünlü Akyüz, Süda Teki̇n, Demet Ofluoğlu, Murat Zi̇nnuroğlu, Pinar Akpinar, Tuğçe Özekli̇ Misirlioğlu, Berri̇n Hüner, Ahmet Hakan Nur
Turkish Journal of Medical Sciences
Spasticity is the most common motor disturbance in cerebral palsy (CP). Lockdown in the COVID-19 outbreak has profoundly changed daily routines, and similarly caused the suspension of spasticity treatment plans. Besides, the delay in botulinum toxin (BoNT) injection, which is important in the management of focal spasticity, led to some problems in children. This consensus report includes BoNT injection recommendations in the management of spasticity during the COVID-19 pandemic in children with CP. In order to develop the consensus report, physical medicine and rehabilitation (PMR) specialists experienced in the field of pediatric rehabilitation and BoNT injections were invited by Pediatric …
Outcome Of Noncritical Covid-19 Patients With Early Hospitalization And Early Antiviraltreatment Outside The Icu, Nursel Çalik Başaran, Oğuz Abdullah Uyaroğlu, Gülçi̇n Telli̇ Di̇zman, Lale Özişik, Taha Koray Şahi̇n, Zahi̇t Taş, Ahmet Çağkan İnkaya, Sevi̇lay Karahan, Şehnaz Özyavuz Alp, Alpaslan Alp, Gökhan Metan, Işkin Pinar Zarakol, Gülay Sai̇n Güven, Şeri̇fe Gül Öz, Arzu Topeli̇ İski̇t
Outcome Of Noncritical Covid-19 Patients With Early Hospitalization And Early Antiviraltreatment Outside The Icu, Nursel Çalik Başaran, Oğuz Abdullah Uyaroğlu, Gülçi̇n Telli̇ Di̇zman, Lale Özişik, Taha Koray Şahi̇n, Zahi̇t Taş, Ahmet Çağkan İnkaya, Sevi̇lay Karahan, Şehnaz Özyavuz Alp, Alpaslan Alp, Gökhan Metan, Işkin Pinar Zarakol, Gülay Sai̇n Güven, Şeri̇fe Gül Öz, Arzu Topeli̇ İski̇t
Turkish Journal of Medical Sciences
Background/aim: Despite the fact that the COVID-19 pandemic has been going on for over 5 months, there is yet to be a standard management policy for all patients including those with mild-to-moderate cases. We evaluated the role of early hospitalization in combination with early antiviral therapy with COVID-19 patients in a tertiary care university hospital. Materials and methods: This was a prospective, observational, single-center study on probable/confirmed COVID-19 patients hospitalized in a tertiary care hospital on COVID-19 wards between March 20 and April 30, 2020. The demographic, laboratory, and clinical data were collected. Results: We included 174 consecutive probable/confirmed COVID-19 …
Clinical Course Of Covid-19 Disease In Immunosuppressed Renal Transplant Patients, Hamad Dhei̇r, Savaş Si̇pahi̇, Selçuk Yaylaci, Esma Seda Çeti̇n, Ahmed Bi̇lal Genç, Necatti̇n Firat, Mehmet Köroğlu, Gürkan Muratdaği, Yakup Tomak, Kezban Özmen Süner, Ömer Faruk Ateş, Oğuz Karabay
Clinical Course Of Covid-19 Disease In Immunosuppressed Renal Transplant Patients, Hamad Dhei̇r, Savaş Si̇pahi̇, Selçuk Yaylaci, Esma Seda Çeti̇n, Ahmed Bi̇lal Genç, Necatti̇n Firat, Mehmet Köroğlu, Gürkan Muratdaği, Yakup Tomak, Kezban Özmen Süner, Ömer Faruk Ateş, Oğuz Karabay
Turkish Journal of Medical Sciences
Background/aim: We aimed to identify clinical settings of renal transplant patients with COVID-19. Materials and methods: In this retrospective study, we included kidney transplant inpatients with laboratory confirmed COVID-19 who had been discharged or had died by October 1st, 2020. Characteristics of the patients, including basal and last outpatient biochemical parameters were recorded. Discontinuation or dosage reduction of immunosuppressives and other treatment information was documented. Results: Twenty patients were included in this study, of whom 18 were discharged and 2 died in hospital. The mean duration of hospitalization and follow-up were 9.7 ± 6.4 days and 4.5 ± 2.0 months, …
Characteristics And Mortality Determinants Of Covid-19 Patients Undergoinghemodialysis, Savaş Si̇pahi̇, Hamad Dhei̇r, Aysel Toçoğlu, Meli̇ke Bektaş, Seyyi̇d Bi̇lal Açikgöz, Ahmed Ci̇had Genç, Fuldem Mutlu, Mehmet Köroğlu, Ali̇ Fuat Erdem, Oğuz Karabay
Characteristics And Mortality Determinants Of Covid-19 Patients Undergoinghemodialysis, Savaş Si̇pahi̇, Hamad Dhei̇r, Aysel Toçoğlu, Meli̇ke Bektaş, Seyyi̇d Bi̇lal Açikgöz, Ahmed Ci̇had Genç, Fuldem Mutlu, Mehmet Köroğlu, Ali̇ Fuat Erdem, Oğuz Karabay
Turkish Journal of Medical Sciences
Background/aim: The COVID-19 infection, which started in Wuhan City, China, in December 2019, turned into a pandemic in a very short time, affecting mainly the elderly and those with serious chronic illnesses. COVID-19 infections have been observed to have a high mortality rate, especially in patients undergoing maintenance hemodialysis. Materials and methods: Forty-two patients over 18 years of age who underwent a maintenance hemodialysis program at our unit, who tested positive for COVID-19 by PCR from nasopharyngeal swabs, and/or who were observed to have disease-related signs in their CTs were included in the study. Results: In this study, 23 of …
Nonpharmaceutical Interventions In Turkey And Worldwide During Covid-19 Pandemic, Mustafa Necmi̇ İlhan, Hakan Tüzün, Rahmi̇ Kiliç, Nuran Yildirim
Nonpharmaceutical Interventions In Turkey And Worldwide During Covid-19 Pandemic, Mustafa Necmi̇ İlhan, Hakan Tüzün, Rahmi̇ Kiliç, Nuran Yildirim
Turkish Journal of Medical Sciences
Nonpharmaceutical interventions (NPIs) are actions apart from getting vaccinated and medications, in order to promote deceleration of the spread of illness among people and communities during pandemic. In this article, we aim to examine NPIs applied in Turkey and worldwide due to the COVID-19 pandemic. Some of the NPIs such as isolation, quarantine, and contact tracing were maintained with updates of the Ministry of Health guidelines in Turkey. Some NPIs including travel and partial or full curfew mobilization restrictions were set in accordance with the various periods by the number of cases. Periods of restrictions at autumn 2021 to summer …
Current Infection Prevention And Control Strategies Of Covid-19 In Hospitals, Gamze Kalin Ünüvar, Mehmet Doğanay, Emi̇ne Alp
Current Infection Prevention And Control Strategies Of Covid-19 In Hospitals, Gamze Kalin Ünüvar, Mehmet Doğanay, Emi̇ne Alp
Turkish Journal of Medical Sciences
Background/aim: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been appeared first in China since December 2019. Transmission of SARS-CoV-2 occurs primarily with droplets through coughing and sneezing and also occurs through inhalation of aerosolized secretions, which travel, remain suspended in the air longer. Materials and methods: Since early stages of the outbreak, COVID-19 cases have been described in healthcare workers (HCWs). However, in the early stages, the disease may be asymptomatic. This may lead to incorrect diagnosis or delayed diagnosis and may lead to the nosocomial spread of the virus. One of the …
Evaluating The Efficiency Of Public Policy Measures Against Covid-19, Hati̇ce Rahmet Güner, İmran Hasanoğlu, Fi̇rdevs Aktaş
Evaluating The Efficiency Of Public Policy Measures Against Covid-19, Hati̇ce Rahmet Güner, İmran Hasanoğlu, Fi̇rdevs Aktaş
Turkish Journal of Medical Sciences
The World Health Organization (WHO) declared COVID-19 as a Public Health Emergency of international concern on January 30, 2020, and a pandemic on March 11, 2020. Afterward, it spread rapidly all over the world, causing almost 4 million deaths as of June 2021. It is clear that effective preventive measures are needed in this devastating disease, which still has no cure. In addition to mask using, social distancing, and hygiene practices, which enter our lives as the most basic precautions, communities aim to reduce the effects of the COVID-19 pandemic. All over the world, the measures taken and activities performed …